Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
- Status
- COMPLETED
- Phase
- N/A
Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI
- Status
- COMPLETED
- Phase
- NA
T-Cell Therapy (ECT204) in Adults With Advanced HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation
- Status
- COMPLETED
- Phase
- NA
Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy
- Status
- COMPLETED
- Phase
- NA
A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).
- Status
- UNKNOWN
- Phase
- PHASE2
Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1"
- Status
- COMPLETED
- Phase
- N/A
Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Surgical Therapy and Survival in HCC/ C.F. Zhang et al.
- Status
- COMPLETED
- Phase
- N/A
PD-1 Antibody and Lenvatinib Plus TACE-HAIC for Potential Resectable HCC: a Single-arm, Phase 2 Clinical Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial
- Status
- UNKNOWN
- Phase
- PHASE2